AHMEDABAD, India, Jan. 2, 2025
/PRNewswire/ -- Veeda Group has unveiled a new logo and brand
identity—Veeda Lifesciences—marking a key milestone in its journey.
The new brand name reflects the evolution from a generics-focused
Contract Research Organization (CRO) to a drug development services
enterprise for different modalities of drugs including generics and
novel chemical and biological entities. Veeda Lifesciences will
operate through four Strategic Business Units: Clinical Trials,
Healthy Volunteer Services, Biopharma Services, and Preclinical
& Non-Clinical Testing Services, making Veeda an integrated
research service provider.
Veeda Lifesciences represents the brand that integrates Veeda
Clinical Research, Health Data Specialists, and Bioneeds India,
showcasing research services across various stages of the drug
development value chain from discovery and preclinical to
late-phase development. The new identity reflects the transition
from generics to innovation, local to global, and small molecules
to biologics. Veeda Lifesciences is transitioning to a CRO-CDMO
model, while leveraging AI & Real-world data.
Dr. Mahesh Bhalgat, Group CEO
and Managing Director of Veeda Lifesciences, stated, "The name
– Veeda Lifesciences – and the new logo, designed to be modern and
dynamic, symbolize the Group's forward-thinking approach and
dedication to its core values and mission. It adds aspirational
value to our growth and vision for the future, striving for
innovation, excellence, and client satisfaction. We continue to
diversify our base offering services serving the growing needs of
our clients."
Founded in India in 2004, Veeda
Lifesciences now operates out of 5 countries while conducting
trials in 26 geographies. The strategic acquisition of Bioneeds in
2021 expanded Veeda into preclinical services. Today, Veeda
Lifesciences offers a broad range of services to the life sciences
and healthcare industries, with reputable sponsors, including
leading global pharma companies. Veeda Lifesciences is now
organized under four strategic business units. The Clinical trials
business comprises of Veeda's operations in Europe (originally Health Data Specialists)
and patient-based clinical trials in India. The Healthy Volunteer Services includes
operations in Gujarat (India)
including clinical bioanalysis for small molecules. The Biopharma
services in Bengaluru (India)
include analytical characterization and functional characterization
of biologics along with cell line and process development and
clinical bioanalysis of large molecules. The preclinical testing
services of Veeda, based in Karnataka (India) includes our discovery research
services in the area of chemistry and biology.
About Veeda Lifesciences:
Veeda Lifesciences platform providing full service as well as
functional service for all the stages of drug development to
support biotech and pharmaceutical companies with capabilities
ranging from Pre-Clinical to Clinical Pharmacology and Clinical
Trials across different modalities. We support multiple therapeutic
domains and accelerate pipelines through advanced real-world data
capabilities on an AI platform. Committed to quality with sound
scientific capabilities, we continuously invest in people and
technology, to help clients in developing innovative therapies and
generic drugs for patients worldwide.
Disclaimer:
Veeda Clinical Research Limited (the "Company") is
proposing, subject to receipt of requisite approvals, market
conditions and other considerations, a public issue of its equity
shares in the near future and is in the process of filing a draft
red herring prospectus with the Securities and Exchange Board of
India. This document is not an
offer of securities for sale in the
United States. Securities may not be offered or sold in
the United States absent
registration or an exemption from registration. Any public offering
of securities to be made in the United
States will be made by means of a prospectus that may be
obtained from the Company and will contain detailed information
about the Company and management, as well as financial statements.
The Company does not intend to register any part of the offering in
the United States.
Logo:
https://mma.prnewswire.com/media/2589459/Veeda_Lifesciences_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/veeda-group-rebrands-as-veeda-lifesciences-302341180.html
